EMA: Concept paper on potency declaration / labelling for biological medicinal products which contain modified proteins as active substance

This concept paper aims to provide the rationale for drafting a guidance document for potency assignment of modified proteins for which an International Standard exists or where a clinical recognised unit exists (without an International Standard established) for the non-modified product.